Moderna (MRNA) Business News

Track Moderna in real time with a live news feed covering Moderna stock news, official press releases, company announcements, and an archive of historical Moderna news. ...more

  • Calendar
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
5:03 PM | Thursday | May 21, 2026 Reuters

Moderna, Merck cancer combo cuts melanoma spread risk at five years

News Thumbnail
11:26 AM | Thursday | May 21, 2026 Reuters

US FDA to hold expert committee meeting to review Moderna's flu vaccine

News Thumbnail
9:36 AM | Thursday | May 21, 2026 24/7 Wall Street

Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now

News Thumbnail
11:26 AM | Thursday | May 21, 2026 Reuters

US FDA to hold expert committee meeting to review Moderna's flu vaccine

News Thumbnail
9:36 AM | Thursday | May 21, 2026 24/7 Wall Street

Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now

News Thumbnail
12:20 PM | Tuesday | May 19, 2026 Seeking Alpha

Moderna, Inc. (MRNA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

News Thumbnail
1:15 PM | Wednesday | May 13, 2026 The Motley Fool

3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally

News Thumbnail
5:00 PM | Tuesday | May 12, 2026 Accesswire

Moderna Recognized by TIME as One of the World's Most Impactful Companies

News Thumbnail
4:50 PM | Tuesday | May 12, 2026 Seeking Alpha

Moderna, Inc. (MRNA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

News Thumbnail
1:25 PM | Tuesday | May 12, 2026 PYMNTS

Moderna's AI Could Get a Hantavirus Vaccine Here Faster

News Thumbnail
11:43 AM | Monday | May 11, 2026 Proactive Investors

Moderna shares extend gains as hantavirus vaccine work draws attention

News Thumbnail
10:53 AM | Monday | May 11, 2026 24/7 Wall Street

Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

News Thumbnail
10:44 AM | Monday | May 11, 2026 Invezz

Moderna stock soars as hantavirus fears spark outbreak trade

News Thumbnail
news photo
Loading...

Moderna and Merck's combination therapy for skin cancer helped reduce risk of cancer spreading to another part of the body ​by 59% after five years of follow-up, data from ‌a mid-stage trial showed Thursday.

Read full article redirect
5:03 PM | Thursday | May 21, 2026

Moderna, Merck cancer combo cuts melanoma spread risk at five years

Reuters

Moderna and Merck's combination therapy for skin cancer helped reduce risk of cancer spreading to another part of the body ​by 59% after five years of follow-up, data from ‌a mid-stage trial showed Thursday.

Read full article arrow
News Thumbnail
11:26 AM | Thursday | May 21, 2026

US FDA to hold expert committee meeting to review Moderna's flu vaccine

Reuters

The U.S. FDA said on Thursday it would hold a meeting of outside experts next ​month to review Moderna's experimental flu shot.

Read full article arrow
News Thumbnail
9:36 AM | Thursday | May 21, 2026

Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now

24/7 Wall Street

Moderna (NASDAQ:MRNA | MRNA Price Prediction) is back in the headlines after ripping 63.17% higher year to date on a surprise Q1 revenue triple and renewed pipeline excitement.

Read full article arrow
News Thumbnail
11:26 AM | Thursday | May 21, 2026

US FDA to hold expert committee meeting to review Moderna's flu vaccine

Reuters

The U.S. FDA said on Thursday it would hold a meeting of outside experts next ​month to review Moderna's experimental flu shot.

Read full article arrow
News Thumbnail
9:36 AM | Thursday | May 21, 2026

Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now

24/7 Wall Street

Moderna (NASDAQ:MRNA | MRNA Price Prediction) is back in the headlines after ripping 63.17% higher year to date on a surprise Q1 revenue triple and renewed pipeline excitement.

Read full article arrow
News Thumbnail
12:20 PM | Tuesday | May 19, 2026

Moderna, Inc. (MRNA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Seeking Alpha

Moderna, Inc. (MRNA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Read full article arrow
News Thumbnail
1:15 PM | Wednesday | May 13, 2026

3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally

The Motley Fool

The hantavirus isn't as contagious as the coronavirus, making a global pandemic unlikely. Picking the potential winners in the hantavirus vaccine market would hardly be worth the time and risk.

Read full article arrow
News Thumbnail
5:00 PM | Tuesday | May 12, 2026

Moderna Recognized by TIME as One of the World's Most Impactful Companies

Accesswire

CAMBRIDGE, MA / ACCESS Newswire / May 12, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked no. 1 on TIME's 2026 list of the World's Most Impactful Companies.

Read full article arrow
News Thumbnail
4:50 PM | Tuesday | May 12, 2026

Moderna, Inc. (MRNA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha

Moderna, Inc. (MRNA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Read full article arrow
News Thumbnail
1:25 PM | Tuesday | May 12, 2026

Moderna's AI Could Get a Hantavirus Vaccine Here Faster

PYMNTS

Drug development has always been a slow business. A single medicine can take 10 to 15 years and cost billions before it reaches a patient.

Read full article arrow
News Thumbnail
11:43 AM | Monday | May 11, 2026

Moderna shares extend gains as hantavirus vaccine work draws attention

Proactive Investors

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) shares continued to extend recent gains on Monday as investors welcomed reports that the company is researching a hantavirus vaccine and advancing early-stage work in the area. Shares of Moderna have added more than 16% in the last five days, trading hands at about $55.

Read full article arrow
News Thumbnail
10:53 AM | Monday | May 11, 2026

Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

24/7 Wall Street

Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up roughly 6% in Monday morning trading, changing hands near $57.52 after Friday's close of $54.35.

Read full article arrow
News Thumbnail
10:44 AM | Monday | May 11, 2026

Moderna stock soars as hantavirus fears spark outbreak trade

Invezz

Moderna shares surged on Monday as investors rushed into vaccine and biotech stocks following reports of a hantavirus outbreak linked to a cruise ship, despite health authorities maintaining that the overall public health risk remains low. The stock rose 9.43% to $59.48, its intraday high after a US national tested mildly positive for the Andes strain of hantavirus.

Read full article arrow
News Thumbnail